Celldex Therapeutics Inc
CLDX
NASDAQ
Biotechnology
$41.95
USD
-0.66 (-1.55%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.39B
Volume 849.4K
Price Target
$42.00 – $100.00
USD
The 4 analysts offering 1-year price forecasts have a max estimate of $100.00 and a min estimate of $42.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$61.75
+$10.8 vs prior
Implied Upside
+47.2%
+25.6% vs prior
Analyst Covering
4
Unchanged vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$9.25 Gap
Median $52.50 vs avg $61.75 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
4 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
4 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Edward Nash | Canaccord Genuity | Buy | Maintained | 3 weeks ago | Plus | Plus | Plus |
Yatin Suneja | Guggenheim | Buy | Maintained | 3 weeks ago | Plus | Plus | Plus |
Joseph Pantginis | HC Wainwright & Co. | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
David Dai | UBS | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
